2.5
2025

Management of anaphylaxis: a cross-sectional study of competence and barriers in use of epinephrine autoinjectors in northern Italy

Show more: Authors information and Publication history
Authors Information

1Allergy Service, Casa di Cura Beato Palazzolo, Bergamo, Italy
2Simple Departmental Unit of Allergology, ASST Spedali Civili, Brescia, Italy
3Department of Clinical and Medical Sciences (Allergy and Clinical Immunology), University of Brescia, Brescia, Italy

History

Published: 10 November 2026
Accepted: 29 October 2026
Received: 09 March 2026

SUMMARY

Background. Epinephrine autoinjectors (EAIs) are the first-line treatment for anaphylaxis, and they are recommended in guidelines on anaphylaxis management. Despite these clear indications, EAIs remain largely underused, with an alarming rate of incorrect administration.
This study evaluates patients’ ability of self-administration of EAIs, the most common mistakes made, and patients’ availability of their own device. Methods. We included patients already in follow-up at the ASST Spedali Civili in Brescia and the Casa di Cura Beato Palazzolo in Bergamo, between February and September 2025. Results. Of 258 patients, 64% performed the self-administration procedure incorrectly. The most frequent mistakes were not removing the safety cap (34%) and removing the device from the site of injection before 10 seconds (24%). The only statistically significant predictive factor associated with the correct use of the device was the physical availability of the autoinjector during the visit. There were no significant correlations with gender, education level, device type, years of adrenaline possession or previous anaphylactic episodes after EAI prescription. When considering new anaphylactic events occurred after the first EAI prescription, 50% of the patients did not use their device due to the lack of recognition of necessity, while 36% did not have their device available. Conclusions. These data confirm that underutilization and misuse of EAI are widespread and persistent problems. Even now, persistent educational path with “face to face” training and a written action plan, to be repeated at each check-up, is not enough to help patients in accepting and managing correctly adrenaline auto-injectors. Scientific community should think of additional or different types of training, maybe considering also the psychological aspects of patients’ anaphylactic experience.

KEY WORDS
Anaphylaxis; adrenaline; autoinjector.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology | ©2026
Online ISSN: 2845-7285 (since 2024) · Print ISSN: 1764-1489 (discontinued in 2023)